Clinical Trial News and Research

RSS

SVC112 molecule acts specifically against head and neck cancer stem cells

The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds.

8 Jan 2020

Insilico and Beiersdorf use next-generation AI technology in skin research

Beiersdorf and Insilico Medicine, an artificial intelligence company developing end to end drug discovery pipelines, announced today that they are entering a collaboration to jointly discover novel, safe bioactive ingredients for a specific skin indication at an unparalleled pace, that will serve as the basis for developing appropriate skincare products.

8 Jan 2020

Airway Therapeutics receives funding to advance BPD treatment

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the injury cycle of inflammation for patients with respiratory and inflammatory diseases, announced today the closing of a $15.5 million oversubscribed Series C financing round.

8 Jan 2020

UChicago expert sheds light on pancreatic neuroendocrine tumors

Pancreatic cancer has been in the national spotlight lately with "Jeopardy" host Alex Trebek revealing his diagnosis. For the majority of all pancreatic cancer cases, the cancer begins in the ducts of the pancreas.

7 Jan 2020

Clinical trial tests experimental stem cell treatment against best available drugs for MS

A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis.

7 Jan 2020

The first clinical trials of CRISPR gene editing have shown promising results

Results of clinical trials testing CRISPR suggest that treating diseases with the gene-editing tool may be on the horizon.

7 Jan 2020

Can FDA-approved flu shots be repurposed as treatments for cancer?

Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies.

7 Jan 2020

New antibody-drug conjugate shows promising activity in salivary gland tumors

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

7 Jan 2020

Phase II case-control trial initiated for four types of terminal cancers

The Alexandrov National Cancer Centre begins phase II case-control clinical trial of its immuno-oncology agent, Elenagen.

7 Jan 2020

Electrical nerve stimulation may help women with fibromyalgia

A treatment involving electrical nerve stimulation helped women with fibromyalgia in a recent clinical trial. The findings are published in Arthritis & Rheumatology.

6 Jan 2020

New clinical study to test retinal screening processes for early detection of Alzheimer's disease

The University of Rhode Island, in collaboration with BayCare Health System in Florida and The Memory and Aging Program at Butler Hospital, an affiliate of The Warren Alpert Medical School of Brown University, is launching a clinical trial of retinal screening processes that could help clinicians detect Alzheimer's disease possibly two or more decades before patients develop life-altering clinical symptoms.

6 Jan 2020

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

A novel method of combining advanced optical imaging with an artificial intelligence algorithm produces accurate, real-time intraoperative diagnosis of brain tumors, a new study finds.

6 Jan 2020

Commercial weight management groups may be helpful for weight loss in postnatal women

Women who were overweight at the start of their pregnancy would welcome support after they have given birth in the form of commercial weight management groups, University of Warwick-led research has found.

6 Jan 2020

CID trials: Adoption of new recommendations could get innovative treatments to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of recommendations, published today in the British Journal of Cancer.

6 Jan 2020

FDA approves Control-IQ artificial pancreas system

The U.S. Food and Drug Administration has approved an artificial pancreas system - based on technology from the University of Virginia Center for Diabetes Technology - that automatically monitors and regulates blood glucose levels.

2 Jan 2020

New trial shows how parents can avoid bringing dangerous bacteria into the NICU

For sick or prematurely born babies spending their first days of life in a hospital's neonatal intensive care unit, the soothing voice and gentle touch of a loving parent can have a tremendous impact toward a positive outcome -- that is, unless mom or dad's visit leaves the infant with something extra: a dangerous bacterial infection.

31 Dec 2019

Yale Cancer Center launches CEHE to ensure health equity and improve patient outcomes

Yale Cancer Center announces the launch of the Center for Community Engagement and Health Equity.

26 Dec 2019

Research findings may one day help keep ALS at bay

A new study published in the journal Nature Medicine on December 23, 2019, shows how to silence a defective gene responsible for the degeneration of the motor neurons in Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), in adult mice. This could help prevent disease progression if the condition is already symptomatic, and even suppress the illness if it has not yet started.

23 Dec 2019

Immunosupressant combination therapy for glioblastoma shows promise

Researchers from the University of Texas have found an immunosuppressing target for the treatment of glioblastoma. In mice studies the team has identified CD73 macrophages which could be used to treat the cancers. The team also performed studies on human tumours to arrive at their conclusions. The study was published in the latest issue of the journal Nature Medicine this week.

23 Dec 2019

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

GB Sciences, Inc. announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council in Halifax, Nova Scotia, CANADA.

22 Dec 2019

Clinical Trial News and Research

SVC112 molecule acts specifically against head and neck cancer stem cells

Insilico and Beiersdorf use next-generation AI technology in skin research

Airway Therapeutics receives funding to advance BPD treatment

UChicago expert sheds light on pancreatic neuroendocrine tumors

Clinical trial tests experimental stem cell treatment against best available drugs for MS

The first clinical trials of CRISPR gene editing have shown promising results

Can FDA-approved flu shots be repurposed as treatments for cancer?

New antibody-drug conjugate shows promising activity in salivary gland tumors

Phase II case-control trial initiated for four types of terminal cancers

Electrical nerve stimulation may help women with fibromyalgia

New clinical study to test retinal screening processes for early detection of Alzheimer's disease

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

Commercial weight management groups may be helpful for weight loss in postnatal women

CID trials: Adoption of new recommendations could get innovative treatments to patients faster

FDA approves Control-IQ artificial pancreas system

New trial shows how parents can avoid bringing dangerous bacteria into the NICU

Yale Cancer Center launches CEHE to ensure health equity and improve patient outcomes

Research findings may one day help keep ALS at bay

Immunosupressant combination therapy for glioblastoma shows promise

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer